Alterity Therapeutics (ATHE) Equity Average (2018)
Alterity Therapeutics (ATHE) has 1 years of Equity Average data on record, last reported at $15.0 million in Q2 2018.
- For Q2 2018, Equity Average changed N/A year-over-year to $15.0 million; the TTM value through Jun 2018 reached $15.0 million, changed N/A, while the annual FY2018 figure was $15.0 million, 26.24% down from the prior year.
- Equity Average reached $15.0 million in Q2 2018 per ATHE's latest filing.
- Across five years, Equity Average topped out at $15.0 million in Q2 2018 and bottomed at $15.0 million in Q2 2018.